TRYMO TABLET contains Colloidal bismuth subcitrate which belongs to the group of medicines called Anti-ulcer agents. TRYMO TABLET is used to manage duodenal and gastric ulceration in affected individuals.
TRYMO TABLET is also used to manage non-ulcer dyspepsia (indigestion) that occurs due to H.pylori associated gastritis (inflammation of stomach), when used in combination with antibiotic therapy. The medicine is also indicated for use in 14 day programme to eradicate H.pylori infection (bacterial infection) with/without association with non-ulcer dyspepsia in affected individuals.
TRYMO TABLET is not recommended for use in patients allergic to Colloidal bismuth subcitrate. It is also not recommended for use in patients suffering from severe renal impairment.
Before taking TRYMO TABLET, inform your doctor if you suffer from liver problems.
TRYMO TABLET is generally not recommended for use during pregnancy and in breastfeeding women unless it is clearly necessary.
TRYMO TABLET should be used with caution in children (aged below 3-years) and is advised to be used with caution in elderly patients (aged 65years/above) after consulting the doctor.
The most common side effects associated with use of TRYMO TABLET are abdominal pain, headache, nausea, vomiting, diarrhoea, black stools, and/or dizziness. Consult your doctor if any of these symptoms worsens.
No content available
